Akèy › Kansè nan tete › Minnesota › Rochester
Etid klinik pou Kansè nan tete nan Rochester, MN
42 etid pou Kansè nan tete ap chèche patisipan nan sit nan ak bò kote Rochester (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
Ap rekriteFaz 2Volontè an sante akeyi
- Mayo Clinic in Rochester, Rochester
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Ap rekriteFaz 2
- Mayo Clinic, Rochester
PRE-ISPY Phase I/II Oncology Platform Program
Ap rekriteFaz 1/2
- Mayo Clinic Comprehensive Cancer Center, Rochester
Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy
Ap rekrite
- Mayo Clinic, Rochester
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Ap rekriteFaz 2
- Mayo Clinic Cancer Center, Rochester
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Ap rekrite
- Mayo Clinic, Rochester
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Ap rekriteFaz 3
- Mayo Clinic in Rochester, Minnesota, Rochester
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
Ap rekriteFaz 2
- Mayo Clinic in Rochester, Minnesota, Rochester
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Ap rekriteFaz 1
- Mayo Clinic - Rochester, Rochester
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
Ap rekriteFaz 2
- Mayo Clinic, Rochester
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Ap rekriteFaz 1/2
- Mayo Rochester, Rochester
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Ap rekriteFaz 3
- Mayo Clinic, Rochester
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
Ap rekriteFaz 1
- Mayo Clinic, Rochester
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
Ap rekriteFaz 1/2
- Mayo Clinic, Rochester
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Ap rekriteFaz 3
- Mayo Clinic in Rochester, Rochester
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Ap rekriteFaz 3
- Mayo Clinic-Comprehensive Cancer Center-Breast Clinic, Rochester
Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer
Ap rekriteFaz 1
- Mayo Clinic, Rochester
Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Mayo Clinic in Rochester, Rochester
A 3D-Printed External Breast Prosthesis for the Improvement of Patient-reported Outcomes Among Breast Cancer Patients That Underwent a Mastectomy Without Reconstruction
Ap rekrite
- Mayo Clinic in Rochester, Rochester
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Ap rekriteFaz 3
- Mayo Clinic in Rochester, Rochester
E-Mindfulness Approaches for Living After Breast Cancer
Ap rekriteFaz 3
- Mayo Clinic in Rochester, Rochester
A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer
Ap rekriteFaz 1
- Mayo Clinic in Rochester, Rochester
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Ap rekriteFaz 1
- Mayo Clinic Rochester, Rochester
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Ap rekriteFaz 1/2
- Mayo Clinic - Rochester, Rochester
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Ap rekriteFaz 3
- Mayo Clinic - Rochester, Rochester
3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer
Ap rekriteFaz 1 bonè
- Mayo Clinic in Rochester, Rochester
Phase 1 Study of CLR 125 in Triple Negative Breast Cancer
Ap rekriteFaz 1
- Mayo Clinic Rochester, Rochester
3D Ultrasound Breast Imaging
Ap rekrite
- Mayo Clinic in Rochester, Rochester
The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.
Ap rekrite
- Mayo Clinic, Rochester
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Ap rekriteFaz 2
- Mayo Clinic, Rochester
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Ap rekriteFaz 3
- Mayo Clinic in Rochester, Rochester
Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis
Ap rekriteFaz 1/2
- Mayo Clinic, Rochester
Collecting Patient-Reported Experiences With Radiation Dermatitis in Breast Cancer Patients Undergoing Radiotherapy
Ap rekriteEtid obsèvasyon
- Mayo Clinic in Rochester, Rochester
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Ap rekriteFaz 1/2
- Mayo Clinic, Rochester
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Ap rekriteEtid obsèvasyon
- Mayo Clinic, Rochester
Development of Patient Derived Xenografts (PDX) in Patients With Breast Cancer
Ap rekriteEtid obsèvasyon
- Mayo Clinic, Rochester
Collection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast Cancer
Ap rekriteEtid obsèvasyon
- Mayo Clinic in Rochester, Rochester
Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring
Ap rekriteEtid obsèvasyon
- Mayo Clinic in Rochester, Rochester
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Mayo Clinic, Rochester
Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities
Ap rekrite
- Mayo Clinic in Rochester, Rochester
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
Ap rekriteFaz 1
- Exelixis Clinical Site #14, Rochester
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer
Ap rekriteFaz 1
- Biotheryx Investigative Site, Rochester
Etid Kansè nan tete nan lòt vil
- New York City, NY134 etid
- Houston, TX126 etid
- Boston, MA111 etid
- Nashville, TN80 etid
- Los Angeles, CA72 etid
- Edison, NJ68 etid
- St. Louis, MO64 etid
- Durham, NC63 etid
- Queens, NY63 etid
- Chicago, IL58 etid
- Philadelphia, PA56 etid
- Dallas, TX55 etid
Lòt etid nan Rochester
- Kansè Poumon ki pa ti selil37 etid
- Kansè Metastatik31 etid
- Kansè (tout kalite)30 etid
- Kansè kolorektal29 etid
- Kansè ovè29 etid
- Myelom Miltip24 etid
- Kansè pwostat22 etid
- Ensifizyans kadyak22 etid
- Kansè pankreyas22 etid
- Kansè poumon20 etid
- Kansè Endomèt20 etid
- Lukemi lenfositè kwonik19 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.